PMGC Holdings (ELAB) Debt Ratio (2022 - 2026)
PMGC Holdings' (ELAB) quarterly Debt Ratio came in at 0.27 in Q2 2026, down 10.68% quarter-over-quarter from 0.3 in Q1 2026.
Analysis
PMGC Holdings (ELAB) Debt Ratio (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed Debt Ratio across 5 years of filings, most recently posting 0.27 for Q2 2026.
- In Q2 2026, Debt Ratio changed N/A year-over-year to 0.27; the TTM figure through Jun 2026 stood at 0.27 (changed N/A YoY), while the FY2025 annual figure was 0.14, changed N/A from the prior year.
- Debt Ratio came in at 0.27 for Q2 2026 at PMGC Holdings, down from 0.3 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.33 in Q3 2023 to a low of 0.04 in Q4 2022.
- Average Debt Ratio over 5 years is 0.2, with a median of 0.23 recorded in 2024.
- Year-over-year, Debt Ratio soared 137.69% in 2023 and tumbled 65.76% in 2024.
- Over 5 years, Debt Ratio stood at 0.04 in 2022, then jumped by 137.69% to 0.09 in 2023, then surged by 30.69% to 0.11 in 2024, then climbed by 21.55% to 0.14 in 2025, then soared by 96.59% to 0.27 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.27 in Q2 2026, 0.3 in Q1 2026, and 0.14 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.26 Bn | 193.27 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 179.66 Bn | 176.48 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.77 Bn | 73.78 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.55 Bn | 48.41 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 33.38 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.68 Bn | 30.40 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn | - |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 | 0.27 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.27 |
| Mar 31, 2026 | 0.30 |
| Dec 31, 2025 | 0.14 |
| Sep 30, 2025 | 0.26 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.22 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.33 |
| Dec 31, 2022 | 0.04 |